GLAND2022-01-012022-03-31in-bse-fin:OneOperatingExpenses01Member GLAND2022-01-012022-03-31in-bse-fin:OneOperatingExpenses02Member GLAND2022-01-012022-03-31in-bse-fin:FourOperatingExpenses01Member GLAND2022-01-012022-03-31in-bse-fin:FourOperatingExpenses02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares GLAND 2021-04-01 2022-03-31 2022-04-04 INR Millions Yearly true Cash Flow Indirect Single segment Pharmaceuticals 2022-01-01 2022-03-31 Audited Standalone 11030140000.00 652340000.00 11682480000.00 6029510000.00 88090000.00 -664680000.00 942460000.00 20320000.00 310750000.00 1150450000.00 7876900000.00 3805580000.00 0.00 3805580000.00 852590000.00 93230000.00 945820000.00 0.00 2859760000.00 0.00 0.00 0.00 0.00 2859760000.00 -1960000.00 2857800000.00 2857800000.00 0.00 164300000.00 1 17.41 17.36 0.00 0.00 17.41 17.36 0.00 0.00 0.00 1. In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) 2015, this Statement of Audited Standalone Financial Results for the quarter and year ended March 31, 2022 ( Audited Standalone Financial Results ) of the Company has been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on May 19, 2022. The statutory auditors have expressed an unmodified opinion on the standalone financial results. 2. The Audited Standalone Financial Results of the Company have been prepared in accordance with the Indian Accounting Standards notified under Section 133 of the Companies Act 2013, as amended read with relevant rules thereunder and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) 2015, as amended (the Listing requirements ). 3. The figures of the fourth quarter are the balancing figures between audited figures in respect of the full financial year and the published unaudited year-to-date figures up to the end of the third quarter of the relevant financial year, which were subjected to a limited review. For notes 4 to 10, refer the signed results uploaded on the stock exchange Single segment 2021-04-01 2022-03-31 Audited Standalone 44007080000.00 2239400000.00 46246480000.00 20468620000.00 256650000.00 366900000.00 3385660000.00 52400000.00 1102960000.00 4422860000.00 30056050000.00 16190430000.00 0.00 16190430000.00 3928800000.00 140080000.00 4068880000.00 0.00 12121550000.00 0.00 0.00 0.00 0.00 12121550000.00 -3850000.00 12117700000.00 12117700000.00 0.00 164300000.00 1 71417980000.00 73.84 73.67 0.00 0.00 73.84 73.67 0.00 0.00 0.00 Other expenses 899200000.00 Power and fuel 251250000.00 Other expenses 3472320000.00 Power and fuel 950540000.00 33260000.00 895010000.00 -5269370000.00 0.00 -309550000.00 0.00 0.00 0.00 0.00 659010000.00 0.00 94360000.00 0.00 1102960000.00 0.00 0.00 0.00 0.00 0.00 -76830000.00 0.00 1386450000.00 46210000.00 0.00 0.00 -42350000.00 0.00 41270000.00 0.00 -4212470000.00 11977960000.00 0.00 0.00 0.00 4065090000.00 0.00 7912870000.00 0.00 76080000.00 0.00 0.00 0.00 0.00 0.00 0.00 3990000.00 5113270000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 107920000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1308170000.00 0.00 -6117180000.00 0.00 -10102290000.00 0.00 0.00 0.00 0.00 0.00 0.00 385520000.00 0.00 0.00 1360000.00 0.00 1920000.00 0.00 33260000.00 0.00 0.00 348980000.00 -1840440000.00 33110000.00 -1807330000.00 4919150000.00 3111820000.00